Published in
American Society for Clinical Investigation, JCI Insight, 21(4), 2019
DOI: 10.1172/jci.insight.128199
Links
Tools
Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer
Journal article published in 2019 by
Louise A. Koopman,
Mikkel G. Terp,
Gijs G. Zom,
Maarten L. Janmaat 
,
Kirstine Jacobsen,
Elke Gresnigt-Van den Heuvel,
Marcel Brandhorst,
Ulf Forssmann,
Freddy de Bree,
Nora Pencheva,
Andreas Lingnau,
Maria A. Zipeto,
Paul W. H. I. Parren,
Esther C. W. Breij ,
Henrik J. Ditzel
,
Kirstine Jacobsen,
Elke Gresnigt-Van den Heuvel,
Marcel Brandhorst,
Ulf Forssmann,
Freddy de Bree,
Nora Pencheva,
Andreas Lingnau,
Maria A. Zipeto,
Paul W. H. I. Parren,
Esther C. W. Breij ,
Henrik J. Ditzel
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 